Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer

Shailesh M. Advani, Quilling Shi, Michael J. Overman, Jonathan M. Loree, Michael Lam, Van Morris, Imad Shureiqi, Bryan Kee, Arvind Dasari, Eduardo Vilar, Amir Mehrvarz Sarshekeh, Huei K. Lin, Shanequa Manuel, Stan Hamilton, Kanwal Raghav, Dipen Maru, Scott Kopetz, Xin Shelley Wang

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

In patients with metastatic colorectal cancer, microsatellite instability was associated with a greater symptom burden, and high levels of CpG island methylator subtype were associated with greater pain. The role of microsatellite instability–associated tumor features, including histologic and immune features in potentially increasing the symptom burden in metastatic colorectal cancer warrants further investigation.

Original languageEnglish (US)
Pages (from-to)48-56.e2
JournalClinical colorectal cancer
Volume19
Issue number1
DOIs
StatePublished - Mar 2020

Keywords

  • Epigenetics
  • Microsatellite instability
  • Patient reported outcomes
  • Survivorship
  • Symptom burden

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer'. Together they form a unique fingerprint.

Cite this